SCHEMBL6925972

SCHEMBL6925972

c1cnc2c(c1)oc1cccnc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.48
HTT P42858 2/20 0.48
HSP90AA1 P07900 2/20 0.48
MMP2 P08253 2/20 0.48
TSHR P16473 2/20 0.48
TP53 P04637 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
LMNA P02545 2/20 0.48
MAPT P10636 2/20 0.48
GMNN O75496 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
MMP9 P14780 1/20 0.48
ALOX15 P16050 1/20 0.48
NFKB1 P19838 1/20 0.48
MMP8 P22894 1/20 0.48
CCR1 P32246 1/20 0.48
THPO P40225 1/20 0.48
MTOR P42345 1/20 0.48
MMP13 P45452 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24623621 0.85 KDM4E (0.37) KDM4EHTTHSP90AA1MMP2TSHR
SCHEMBL148991 0.84 KMT2A (0.58) KDM4EHTTHSP90AA1TSHRSMN1; SMN2
SCHEMBL29625837 0.84 KMT2A (0.58) KDM4EHTTHSP90AA1TSHRSMN1; SMN2
SCHEMBL27174137 0.84 KMT2A (0.58) KDM4EHTTHSP90AA1TSHRSMN1; SMN2
SCHEMBL17051497 0.84 KDM4E (0.47) KDM4EHTTHSP90AA1MMP2TSHR
SCHEMBL22483134 0.83 MAPK14 (0.39) KDM4EHTTHSP90AA1MMP2TSHR
Triphenylene SCHEMBL29177920 0.82 KMT2A (0.56) KDM4EHTTHSP90AA1TSHRSMN1; SMN2
SCHEMBL23177440 0.82 SMN1; SMN2 (0.39) KDM4EHTTHSP90AA1MMP2TSHR
SCHEMBL16406207 0.82 CCR1 (0.40) KDM4EHTTHSP90AA1MMP2TSHR
SCHEMBL20005635 0.80 KMT2A (0.50) KDM4EHTTHSP90AA1MMP2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 US disclosed
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 US disclosed
EP-4266393-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, AND METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT Nippon Shokubai Co., Ltd. (JP) 2023-10-25 EP disclosed
US-20230192695-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS UNIV ARIZONA STATE (US) 2023-06-22 US disclosed
US-20230192695-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS UNIV ARIZONA STATE (US) 2023-06-22 US disclosed
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 US disclosed
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 US disclosed
US-20230006159-A1 ORGANIC THIN FILM, METHOD FOR PRODUCING ORGANIC THIN FILM, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, ORGANIC THIN FILM SOLAR CELL, THIN FILM TRANSISTOR, PHOTOELECTRIC CONVERSION ELEMENT, COATING COMPOSITION AND MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS NIPPON SHOKUBAI CO., LTD. (JP) 2023-01-05 US disclosed
US-20220223794-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND APPLICATION THEREOF Wuhan Tianma Microelectronics Co., Ltd. Shanghai Branch (CN) 2022-07-14 US disclosed
EP-4026836-A1 ORGANIC THIN FILM, METHOD FOR PRODUCING ORGANIC THIN FILM, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, ORGANIC THIN FILM SOLAR CELL, THIN FILM TRANSISTOR, PHOTOELECTRIC CONVERSION ELEMENT, COATING COMPOSITION AND MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS Nippon Hoso Kyokai (JP) 2022-07-13 EP disclosed
US-20120187381-A1 Electron Transporting Compounds UNIVERSAL DISPLAY CORPORATION (US) 2012-07-26 US disclosed
US-20120187381-A1 Electron Transporting Compounds UNIVERSAL DISPLAY CORPORATION (US) 2012-07-26 US disclosed
US-8227801-B2 Bicarbzole containing compounds for OLEDs UNIVERSAL DISPLAY CORPORATION (US) 2012-07-24 US disclosed
US-20120021897-A1 RING COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-01-26 US disclosed
US-20120021897-A1 RING COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-01-26 US disclosed
US-20110260138-A1 BICARBZOLE CONTAINING COMPOUNDS FOR OLEDS UNIVERSAL DISPLAY CORPORATION (US) 2011-10-27 US disclosed
US-20030203901-A1 Methods of modulating tyrosine protein kinase function with indolinone compounds SUGEN, INC. 2003-10-30 US disclosed
US-6514981-B1 By contacting cells expressing said protein tyrosine kinase with compound SUGEN, INC. 2003-02-04 US disclosed
EP-1066257-A2 HETEROCYLIC CLASSES OF COMPOUNDS FOR THE MODULATING TYROSINE PROTEIN KINASE Sugen, Inc. (US) 2001-01-10 EP disclosed
WO-1999048868-A2 HETEROCYCLIC CLASSES OF COMPOUNDS FOR THE MODULATING TYROSINE PROTEIN KINASE SUGEN, INC. (US) 1999-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223794-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND APPLICATION THEREOF NR0B2, FPR3, NPR3 KDM4E 3659/4885HTT 3470/4885HSP90AA1 4200/4885
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF AHR, ORAI3, WNT3 KDM4E 3942/4885HTT 613/4885HSP90AA1 4234/4885
US-20120021897-A1 RING COMPOUND NR4A2, NR4A1, NR0B1 KDM4E 2123/4885HTT 4737/4885HSP90AA1 2684/4885
US-20230192695-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS TTPA, TTC14, AAAS KDM4E 3740/4885HTT 960/4885HSP90AA1 226/4885
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, OCIAD2, EHD1 KDM4E 2555/4885HTT 26/4885HSP90AA1 3053/4885
US-20120187381-A1 Electron Transporting Compounds SLC19A2, ABCB7, SLCO2B1 KDM4E 1763/4885HTT 885/4885HSP90AA1 2268/4885
US-20110260138-A1 BICARBZOLE CONTAINING COMPOUNDS FOR OLEDS OCIAD1, OCIAD2, BRD7 KDM4E 1489/4885HTT 1917/4885HSP90AA1 3596/4885
US-20030203901-A1 Methods of modulating tyrosine protein kinase function with indolinone compounds LCK, ABL1, PNCK KDM4E 1320/4885HTT 1285/4885HSP90AA1 1259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.